Literature DB >> 17309647

Associations between USF1 gene variants and cardiovascular risk factors in the Quebec Family Study.

A C Choquette1, L Bouchard, A Houde, C Bouchard, L Pérusse, M-C Vohl.   

Abstract

Cardiovascular (CVD) risk factors are under the influence of environmental and genetic factors. Human upstream transcription factor 1 gene (USF1) encodes for a transcription factor, which modulates the expression of genes involved in lipid and carbohydrate metabolic pathways. The aim of this study was to test the hypothesis that USF1 gene variants are associated with CVD risk factors in the Quebec Family Study (QFS). USF1 has been sequenced in 20 QFS subjects with high plasma apolipoprotein B100 (APOB) levels (>1.14 g/l) and small, dense low-density lipoprotein (LDL) particles (> or =250.7 Angstroms and < or =255.9 Angstroms), as well as in five subjects with larger LDL particles. Ten variants were identified in non-coding regions of USF1. Two of these polymorphisms (intron 7 c.561-100 G>A, and exon 11 c.*187 C>T) as well as the c.-56 A>G polymorphism, were genotyped and analyzed in 760 subjects from QFS. Association studies showed that women with c.561-100 A/A and c.*187 T/T genotypes had more favorable adiposity indices (<0.04). In summary, significant associations between relatively common USF1 genetic variants and CVD risk factors were observed in French Canadians.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17309647     DOI: 10.1111/j.1399-0004.2007.00755.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  8 in total

1.  Genome-wide association study identifies novel recessive genetic variants for high TGs in an Arab population.

Authors:  Prashantha Hebbar; Rasheeba Nizam; Motasem Melhem; Fadi Alkayal; Naser Elkum; Sumi Elsa John; Jaakko Tuomilehto; Osama Alsmadi; Thangavel Alphonse Thanaraj
Journal:  J Lipid Res       Date:  2018-08-14       Impact factor: 5.922

2.  Upstream transcription factor 1 influences plasma lipid and metabolic traits in mice.

Authors:  Sulin Wu; Rebecca Mar-Heyming; Eric Z Dugum; Nicholas A Kolaitis; Hongxiu Qi; Päivi Pajukanta; Lawrence W Castellani; Aldons J Lusis; Thomas A Drake
Journal:  Hum Mol Genet       Date:  2009-12-08       Impact factor: 6.150

3.  Association analysis of USF1 gene polymorphisms and total unstable carotid plaque area in atherosclerotic stroke patients.

Authors:  Rui-Min Wang; Zhi-Zhong Liu; Yan-Hua Gong; Li-Jun Chen; Qian Jia; Ya-Jie Wang; Fang Fang; Hong Lv; Guo-Jun Zhang; Xi-Xiong Kang
Journal:  J Thromb Thrombolysis       Date:  2013-10       Impact factor: 2.300

4.  Genetic variants associated with fasting blood lipids in the U.S. population: Third National Health and Nutrition Examination Survey.

Authors:  Man-huei Chang; Ajay Yesupriya; Renée M Ned; Patricia W Mueller; Nicole F Dowling
Journal:  BMC Med Genet       Date:  2010-04-20       Impact factor: 2.103

5.  Association analysis of allelic variants of USF1 in coronary atherosclerosis.

Authors:  Kati Kristiansson; Erkki Ilveskoski; Terho Lehtimäki; Leena Peltonen; Markus Perola; Pekka J Karhunen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-02-14       Impact factor: 8.311

6.  The rs2516839 Polymorphism of the USF1 Gene May Modulate Serum Triglyceride Levels in Response to Cigarette Smoking.

Authors:  Pawel Niemiec; Tomasz Nowak; Tomasz Iwanicki; Sylwia Gorczynska-Kosiorz; Anna Balcerzyk; Jolanta Krauze; Wladyslaw Grzeszczak; Maria Wiecha; Iwona Zak
Journal:  Int J Mol Sci       Date:  2015-06-10       Impact factor: 5.923

7.  DGAT2-MOGAT2 SNPs and Gene-Environment Interactions on Serum Lipid Profiles and the Risk of Ischemic Stroke.

Authors:  Yong-Gang Zhou; Rui-Xing Yin; Feng Huang; Jin-Zhen Wu; Wu-Xian Chen; Xiao-Li Cao
Journal:  Front Cardiovasc Med       Date:  2021-11-24

8.  Variations in the transcriptome of Alzheimer's disease reveal molecular networks involved in cardiovascular diseases.

Authors:  Monika Ray; Jianhua Ruan; Weixiong Zhang
Journal:  Genome Biol       Date:  2008-10-08       Impact factor: 13.583

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.